Oops, post cut short. Cut and paste getting beyond me!
By the definition I see now why the Board would seek a 'legal' option first and foremost, however I wonder what counsel was behind their own lack of understanding regarding 'novel' devices-an adjective used repeatedly in their 26-year announcement history.
Seems the answer was under their noses all the time.
And hindsight does not cut it. A terrific blunder that ran its course despite being doomed at the outset.
Ann: Optiscan Intends to pursue De Novo Pathway for InVivage, page-41
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $125.3M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $22.24K | 149.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 91022 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 700 | 1 |
View Market Depth
| Last trade - 15.38pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
14.5¢ |
Change
-0.005 ( 6.45 %) |
||||
| Open | High | Low | Volume | ||
| 14.5¢ | 14.5¢ | 14.5¢ | 12503 | ||
| Last updated 12.17pm 14/06/2024 ? | |||||
| OIL (ASX) Chart |